Factors affecting recurrence and progression in superficial bladder tumours.
about
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancerIntravesical gemcitabine for non-muscle invasive bladder cancerIntravesical gemcitabine for non-muscle invasive bladder cancerIntravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancerDefining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancerSmall molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosisPredicting tumor outcomes in urothelial bladder carcinoma: turning pathways into clinical biomarkers of prognosis.Bladder carcinoma data with clinical risk factors and molecular markers: a cluster analysis.A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer.Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.Assessment of the infiltrative character of bladder cancer at the time of transurethral resection: a single center study.Update on the management of non-muscle invasive bladder cancer.Long-term oncologic outcomes after radical cystectomy for bladder cancer at a single institution.Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer.The management of superficial bladder cancer.Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis.The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancerBladder cancer: epidemiology, diagnosis, and management.Epidermal growth factor receptor and bladder cancer.Detection of bladder cancer using novel DNA methylation biomarkers in urine sedimentsA novel transurethral resection technique for superficial flat bladder tumor: grasp and bite techniqueThe evaluation of the risk factors for non-muscle invasive bladder cancer (NMIBC) recurrence after transurethral resection (TURBt) in Chinese population.Multivariate analysis of the prognostic significance of resection weight after transurethral resection of bladder tumor for non-muscle-invasive bladder cancer.Common genetic polymorphisms in pre-microRNAs and risk of bladder cancer.Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection.The management of superficial transitional cell carcinoma of the bladder: a critical assessment of contemporary concepts and future perspectives.Novel fluorescence in situ hybridization-based definition of bacille Calmette-Guérin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies.Immunohistochemical evaluation of cell cycle regulators: impact on predicting prognosis in stage t1 urinary bladder cancer.Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.The pathology of bladder cancer: An update on selected issues.Prognostic utility of human complement factor H related protein test (the BTA stat Test).The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopyNomograms for prediction of disease recurrence in patients with primary Ta, T1 transitional cell carcinoma of the bladder.Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer.Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.Urothelial carcinoma of the bladder: definition, treatment and future efforts.DNA methylation-based biomarkers in bladder cancer.Alterations of DNA methylome in human bladder cancer.
P2860
Q24188046-F7E6D191-DEC5-4D34-BB94-59B42C94D7B6Q24203884-E520C326-2774-4BFF-97EF-BF789F2FB322Q24236635-EB46AA40-BD85-47DF-B167-F7381075A705Q24247924-FEC9FAC5-E089-4881-8472-3E47A786AC8CQ26852084-4A6F0C4B-DBD1-46C9-A73C-A26476E114A5Q27851612-A3A342ED-1A6A-4CFC-8A84-883E068E731CQ30439612-E7EB2682-2EFA-4055-B1DD-00E648EE14EAQ30446429-DE70EC67-64EE-409D-9241-83DA657D9151Q30930265-99C2CBF9-2CFA-4E22-A730-B3358DD4A271Q31944288-549F3F2C-03FA-43A1-B30A-6D484822B466Q33407701-CCA3A3F0-7857-49E3-9E0A-257B646BC5D7Q33609741-9B88A538-F56C-4601-B1EA-9F591638EADEQ33613070-B4A016BC-CCD3-45AA-BCD8-D197645F5D6AQ33627559-DB21AAB1-4C04-4C4E-AF19-6F8607C43124Q33648431-B5FB9BC2-AA32-4B6B-A70C-10A2F4E0E6B8Q34062336-9F1B6C81-55ED-45A2-95D2-13FF99DE1F49Q34135229-DA1DB8C5-C351-4D03-BB6B-51AF8C0BD01EQ34318570-53BF0B66-2F24-46C1-A303-87D75A2F9613Q34452006-3418B70B-FFF8-4ABA-ACCE-63D5CA6D2809Q34983298-8004F3A1-5ECD-4AFF-907A-630F5038664AQ34988074-BAB47808-D7F1-4D99-9BA6-750A3ECAD5F6Q35093755-83AFB4BC-4396-41C9-93AC-296316707364Q35164825-B199AA87-53C6-4D10-85F0-F726A8D98849Q35300254-0F0482B7-9EF8-4BF4-AA97-F765BA7A83A1Q36120400-1017139C-35F3-4578-B90D-C10429B569CFQ36156276-9CCDC667-8239-4A18-A04E-56D44B1C9F5FQ36307223-53B3AB4E-A7FC-4405-8FBC-22814D776C28Q36312232-3896BDEB-DD9E-4709-AAF5-0DD1DBB7F9CDQ36338886-56455C9C-861C-4886-8C95-21DEC4712942Q36470349-008E1F33-3F44-4C70-9644-EA025B8DD13FQ36545629-DDE23611-1668-4077-860D-5C578BF6CDE5Q36552067-EED31975-2F3E-4364-9B83-CBBF79E7BEF4Q36623576-7C31DF2C-ED25-4063-B8CE-BB5D98A885E8Q36786491-AE250F6A-2F48-4B28-9F58-246D4A31DB32Q36854613-D54C21DD-3FD7-4F22-B73A-930DBEF05A7AQ37226438-2FB270B0-32EC-49ED-98BF-A4386BDA0F9DQ37697790-E8B94B49-D633-4AEF-8689-17FE61B5273EQ37944437-79F18F33-3EA4-41C0-90E3-40A671F109A5Q38102879-36D4A8D3-6516-465B-BAD5-F6FAC3FEE3C0Q38131409-FEDD6DAB-17B4-474B-87E6-559113FA2F14
P2860
Factors affecting recurrence and progression in superficial bladder tumours.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Factors affecting recurrence and progression in superficial bladder tumours.
@en
Factors affecting recurrence and progression in superficial bladder tumours.
@nl
type
label
Factors affecting recurrence and progression in superficial bladder tumours.
@en
Factors affecting recurrence and progression in superficial bladder tumours.
@nl
prefLabel
Factors affecting recurrence and progression in superficial bladder tumours.
@en
Factors affecting recurrence and progression in superficial bladder tumours.
@nl
P2093
P1476
Factors affecting recurrence and progression in superficial bladder tumours.
@en
P2093
C Bouffioux
F M Debruyne
M Pavone-Macaluso
R Sylvester
W Oosterlinck
P304
P356
10.1016/0959-8049(95)00287-S
P577
1995-10-01T00:00:00Z